Cyclerion Therapeutics (CYCN) Cash from Operations Growth (3y) (2021 - 2025)
Cyclerion Therapeutics (CYCN) Cash from Operations Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Cyclerion Therapeutics |
11.50 Mn |
8.26 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
70.14% |
| Jun 30, 2025 |
64.04% |
| Mar 31, 2025 |
57.75% |
| Dec 31, 2024 |
26.86% |
| Sep 30, 2024 |
39.95% |
| Jun 30, 2024 |
41.45% |
| Mar 31, 2024 |
49.42% |
| Dec 31, 2023 |
52.12% |
| Sep 30, 2023 |
22.76% |
| Jun 30, 2023 |
22.75% |
| Mar 31, 2023 |
40.28% |
| Dec 31, 2022 |
31.76% |
| Sep 30, 2022 |
25.33% |
| Jun 30, 2022 |
21.03% |
| Mar 31, 2022 |
27.92% |
| Dec 31, 2021 |
28.03% |
| Sep 30, 2021 |
32.10% |
| Jun 30, 2021 |
37.55% |
| Mar 31, 2021 |
18.22% |
